Financhill
Back

Catalyst Pharmaceuticals 10K Form

Buy
66

CPRX
Catalyst Pharmaceuticals

Last Price:
17.51
Seasonality Move:
14.5%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CPRX News And Ratings

See the #1 stock for the next 7 days that we like better than CPRX

CPRX Financial Statistics

Sales & Book Value

Annual Sales: $398.2M
Cash Flow: $31.73M
Price / Cash Flow: 24.61
Annual Sales: $4.76
Price / Book: 3.69

Profitability

EPS (TTM): 0.54000
Net Income (TTM): $65.12M
Gross Margin: $346.24M
Return on Equity: 16.22%
Return on Assets: 13.67%

Catalyst Pharmaceuticals Earnings Forecast

Key Catalyst Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 22 years for CPRX is 86.95%.
  • The Selling, General & Administrative Expenses for CPRX have been equal to 33.58% of Gross Profit Margin.
  • The Research & Development expenses have been 23.39% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • Per Share Earnings over the last 22 years have been positive in 10 years.

Catalyst Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: CPRX
CUSIP: 14888U
Website: catalystpharma.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 5.09
Quick Ratio: 4.66

Price-to-Earnings

Trailing P/E Ratio: 27.87
Forward P/E Ratio: 9.06

CPRX Technical Analysis vs Fundamental Analysis

Buy
66
Catalyst Pharmaceuticals (CPRX) is a Buy

Is Catalyst Pharmaceuticals a Buy or a Sell?